Regulating advanced therapies in the UK: an interview with Michael Rawlins
In this interview with Professor Sir Michael Rawlins, chairman, Medicines and Healthcare products Regulatory Agency, learn more about the future of regenerative medicine in the UK.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.